What is Emergent Biosolutions's gross profit?

Emergent Biosolutions (EBS) reported gross profit of $84.1M in Q1 2026.

How has Emergent Biosolutions's gross profit changed year-over-year?

Emergent Biosolutions's gross profit decreased by 37.1% year-over-year, from $133.7M to $84.1M.

What is the long-term trend for Emergent Biosolutions's gross profit?

Over 3 years (2022 to 2025), Emergent Biosolutions's gross profit has grown at a -0.6% compound annual growth rate (CAGR), from $424.1M to $416.7M.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Emergent Biosolutions EBS Gross Profit

Gross Profit at other companies

AMP

Amphastar PharmaceuticalsAMPH

$70.32M-17.5%

Amneal Pharmaceuticals, Inc.AMRX

$320.11M+25.1%

Collegium Pharmaceutical, Inc.COLL

$117.25M+20.5%

Opko HealthOPK

$45.76M+7.4%

West Pharmaceutical ServicesWST

$296.4M+27.8%

Medline, Inc. MDLN

$1.84B+0.9%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

$156.1Mtotal revenue−$72.0Mtotal cost of revenue=$84.1M

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's gross profit?: Emergent Biosolutions (EBS) reported gross profit of $84.1M in Q1 2026.
How has Emergent Biosolutions's gross profit changed year-over-year?: Emergent Biosolutions's gross profit decreased by 37.1% year-over-year, from $133.7M to $84.1M.
What is the long-term trend for Emergent Biosolutions's gross profit?: Over 3 years (2022 to 2025), Emergent Biosolutions's gross profit has grown at a -0.6% compound annual growth rate (CAGR), from $424.1M to $416.7M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.